BB&T Securities LLC boosted its stake in PetIQ Inc (NASDAQ:PETQ) by 28.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,204 shares of the company’s stock after purchasing an additional 2,924 shares during the period. BB&T Securities LLC’s holdings in PetIQ were worth $366,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Calamos Advisors LLC boosted its holdings in PetIQ by 17.2% in the 3rd quarter. Calamos Advisors LLC now owns 198,303 shares of the company’s stock valued at $5,405,000 after purchasing an additional 29,168 shares during the period. Occidental Asset Management LLC bought a new position in PetIQ in the 3rd quarter valued at $1,254,000. Envestnet Asset Management Inc. boosted its holdings in PetIQ by 2.6% in the 3rd quarter. Envestnet Asset Management Inc. now owns 28,163 shares of the company’s stock valued at $768,000 after purchasing an additional 709 shares during the period. Peregrine Capital Management LLC boosted its holdings in PetIQ by 3.4% in the 3rd quarter. Peregrine Capital Management LLC now owns 668,462 shares of the company’s stock valued at $18,222,000 after purchasing an additional 22,039 shares during the period. Finally, Macquarie Group Ltd. boosted its holdings in PetIQ by 5.2% in the 2nd quarter. Macquarie Group Ltd. now owns 72,605 shares of the company’s stock valued at $2,393,000 after purchasing an additional 3,562 shares during the period. Institutional investors and hedge funds own 86.82% of the company’s stock.
In other news, insider Will Santana sold 10,000 shares of PetIQ stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $32.34, for a total transaction of $323,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO John Newland acquired 44,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were bought at an average cost of $22.28 per share, with a total value of $980,320.00. Following the completion of the acquisition, the chief financial officer now directly owns 44,000 shares in the company, valued at approximately $980,320. The disclosure for this purchase can be found here. Insiders own 23.79% of the company’s stock.
A number of analysts have recently issued reports on the stock. ValuEngine downgraded shares of PetIQ from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. BidaskClub downgraded shares of PetIQ from a “hold” rating to a “sell” rating in a report on Saturday, September 7th. Finally, Zacks Investment Research downgraded shares of PetIQ from a “hold” rating to a “sell” rating in a report on Tuesday. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $37.25.
PetIQ Company Profile
PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.
Further Reading: 52-Week High/Low
Want to see what other hedge funds are holding PETQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetIQ Inc (NASDAQ:PETQ).
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.